Vaccines biology involves the intricate interplay between the immune system and the components of vaccines designed to induce protective immunity. Vaccines leverage the biological principles of immunology to train the immune system to recognize and combat specific pathogens. Vaccine antigens, derived from viruses, bacteria, or other infectious agents, stimulate the production of antibodies and activate immune cells. Memory cells generated during vaccination provide a rapid and robust response upon subsequent exposure to the actual pathogen, conferring immunological memory. Various vaccine types exist, including live attenuated, inactivated, subunit, and mRNA vaccines, each exploiting different biological mechanisms to elicit immune responses. Live attenuated vaccines mimic natural infections, stimulating strong and long-lasting immunity, while inactivated vaccines utilize killed pathogens to trigger immune responses. Adjuvants, another essential component, enhance the immune response to vaccine antigens. They function by activating immune cells and promoting the production of cytokines, amplifying the overall effectiveness of the vaccine. Understanding the biological principles governing vaccines is pivotal for their design, development, and optimization. Ongoing research in vaccines biology continually refines our knowledge, leading to the creation of safer, more effective vaccines against a broad spectrum of infectious diseases.
Title : A promising novel approach to DNA vaccines
Khursheed Anwer, IMUNON, United States
Title : Nanoscopic SubATVax™ adjuvanted vaccines against influenza A types H3N2, H1N1 and influenza type B for subcutaneous administration
David Craig Wright, D4 Labs, LLC, United States
Title : The importance of post-marketing surveillance and real-world data: For a product to be successful
Regina Au, BioMarketing Insight, United States
Title : Prophylactic and molecular approaches for mitigating human influenza A viruses: i. Evaluating influenza vaccine effectiveness in the older population ii. Down-regulation of influenza virus genes with novel sirna-chimeric-ribozyme constructs
Madhu Khanna, University of Delhi, India
Title : Homology analysis of MPXV and VACV peptides underscores the need to consider both MPXV clades for vaccine development
Lara Isis Teodoro, Mayo Clinic, United States
Title : High seroprevalence of RSV antibodies in adults indicates potential undetected transmission and requires further public health assessment
Lara Isis Teodoro, Mayo Clinic, United States
Title : Commensal bacteria drive B-cell lymphomagenesis in the setting of innate immunodeficiency
Ping Xie, Rutgers University, United States
Title : The role of immunity in the pathogenesis of SARS-COV-2 and in the protection generated by COVID-19 in different age groups
Ahmed Abdulazeez, BHRUT Trust, United Kingdom
Title : Establishing a platform method for physical appearance assessment of new parenteral pharmaceuticals
Ying Wan, Merck & Co., United States
Title : Tubercular disease in children: Optimizing treatment strategies through disease insights
Elena Chiappini, University of Florence, Italy